The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive biomarkers of systemic treatment in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials.
 
Caitlin McIntyre
No Relationships to Disclose
 
Esther Dekker
No Relationships to Disclose
 
Mithat Gonen
Consulting or Advisory Role - Delfi Diagnostics
Travel, Accommodations, Expenses - Genentech
 
Marc Besselink
Research Funding - Ethicon/Johnson & Johnson; Intuitive Surgical; Medtronic; Oncosil; Viatris; Viatris
 
Marjolein Homs
No Relationships to Disclose
 
Bianca Mostert
Honoraria - Amgen Astellas BioPharma
Consulting or Advisory Role - AstraZeneca (Inst); BMS GmbH & Co. KG (Inst)
Research Funding - BMS GmbH & Co. KG (Inst)
 
Ching-Wei Tzeng
Honoraria - PanTher Therapeutics
Research Funding - Sirtex Medical (Inst)
 
Eileen O'Reilly
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Autem Medical (I); Berry Genomics (I); BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Eisai (I); Exelixis (I); Genentech/Roche (I); Ipsen; J-Pharma (I); Merck; Merus; Novartis; QED Therapeutics (I); Revolution Medicines; SERVIER (I); Vector Health (I); Yiviva (I)
Research Funding - Agenus (Inst); Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Digestive Care (Inst); Elicio Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Parker Institute for Cancer Immunotherapy (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Revolution Medicines (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma
 
Bas Groot Koerkamp
Research Funding - Tricumed (Inst)